1. Home
  2. PD vs KTTA Comparison

PD vs KTTA Comparison

Compare PD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$6.76

Market Cap

636.9M

Sector

Technology

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.79

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
KTTA
Founded
2009
2020
Country
United States
United States
Employees
N/A
5
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.9M
19.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PD
KTTA
Price
$6.76
$0.79
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$12.63
$3.00
AVG Volume (30 Days)
1.9M
307.9K
Earning Date
05-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
1.87
N/A
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
N/A
Revenue Next Year
$2.88
N/A
P/E Ratio
$3.57
N/A
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$0.28
52 Week High
$17.45
$2.06

Technical Indicators

Market Signals
Indicator
PD
KTTA
Relative Strength Index (RSI) 48.83 54.86
Support Level $6.01 $0.67
Resistance Level $7.91 $0.87
Average True Range (ATR) 0.38 0.06
MACD -0.03 0.00
Stochastic Oscillator 27.08 45.64

Price Performance

Historical Comparison
PD
KTTA

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: